Skip to search.
 TSX Down 0.13% TSX Ventures Up 0.29%

CTI BioPharma Corp. (CTIC)

-NasdaqCM
0.33 Down 0.01(2.37%) 12:23PM EDT - Nasdaq Real Time Price
Prev Close:0.33
Open:0.34
Bid:0.33 x 9400
Ask:0.33 x 400
1y Target Est:1.92
Beta:0.563461
Earnings Date:Aug 4 - Aug 8 (Est.)
Day's Range:0.33 - 0.33
52wk Range:0.25 - 1.90
Volume:653,954
Avg Vol (3m):1,393,750
Market Cap:92.20M
P/E (ttm):N/A
EPS (ttm):-0.43
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
CTICDown 2.37%92.20M
BMYDown 1.97%125.13B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):1.86
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :-0.25
Quarterly EPS Est (Jun-16) :-0.10
Mean Recommendation*:3.3
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

CTI BioPharma Corp., a biopharmaceutical company, engages in the acquisition, development, and commercialization of novel targeted therapies for blood-related cancers in the United States and internationally. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback